Literature DB >> 1964623

Atrophy, hormones, genes and viruses in aetiology germ cell tumours.

R T Oliver1.   

Abstract

This chapter reviews the evidence that testicular germ cell atrophy could be the final common pathway for all of the established and postulated risk factors for induction of testis tumours. The evidence from age incidence studies shows that the tumour peak incidence follows the curve of sexual activity in the male, and this provides the starting point for the argument that this tumour is dependent on endocrine factors for its induction. The data from epidemiological studies confirming the high frequency of atrophogenic events and occurrence of low sperm counts in more than 75% of patients provide the principal evidence in support of this hypothesis. The need for more information on hormone sensitivity of this group of tumours and in particular the more differentiated variety, ie seminoma, is highlighted. Information on levels of DNA repair enzyme activity as an explanation of radiosensitivity and chemosensitivity of this group of tumours is also needed. The relationship of HLA linked immune response genes to susceptibility to testicular atrophogenic virus infection needs further investigation, particularly in view of the recent introduction of widespread prepubertal vaccination against mumps virus, one of the most clearly identified testicular atrophogenic viruses. The paper concludes with an examination of the influence of carcinogens and radiation and how they relate to modern ideas of clonal evolution of tumours. The conclusion from this review is that testicular germ cell tumours provide an excellent model of the recent postulate of Ames et al, (1990) that for some cancers mitogenesis might precede mutagenesis, in contrast to the classical view produced from animal models that mutagenic induction is followed by mitogenic promotion.

Entities:  

Mesh:

Year:  1990        PMID: 1964623

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  14 in total

1.  Hurricane growth of malignant trophoblastic teratoma.

Authors:  M A Raja; R T Oliver; M Blomley
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

Review 2.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark.

Authors:  H Møller; A Prener; N E Skakkebaek
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

Review 4.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

5.  An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States).

Authors:  X O Shu; M E Nesbit; J D Buckley; M D Krailo; L L Robinson
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

Review 6.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

7.  Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group.

Authors: 
Journal:  BMJ       Date:  1994-05-28

Review 8.  Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors.

Authors:  T Strohmeyer
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  A segregation analysis of testicular cancer based on Norwegian and Swedish families.

Authors:  K Heimdal; H Olsson; S Tretli; S D Fosså; A L Børresen; D T Bishop
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Gonadal atrophy as a cause of thymic hyperplasia after chemotherapy.

Authors:  P Sperandio; P Tomio; R T Oliver; M V Fiorentino; F Pagano
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.